Motilal Oswal Sees 80% Upside for Zydus Wellness; Stock Jumps 11%

• Motilal Oswal initiated 'Buy' on Zydus Wellness, projecting an 80% upside in its bull case scenario.
• The brokerage set a price target of ₹575, implying a 35% upside from current levels.
• Zydus Wellness is a diversified health and nutrition company with ₹4,000 crore annual revenue, leading in categories like Sugar Free and GluconD.
• Recent acquisitions (Naturell, Comfort Click) have expanded its presence in high-protein snacking and preventive healthcare.
• Stock trades at a 30-35% discount to FMCG peers; Motilal expects 36% consolidated EBITDA CAGR over FY25-FY28.

Why It Matters: Motilal Oswal projects significant upside for Zydus Wellness, citing strong fundamentals and growth potential.